A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours
Status:
RECRUITING
Trial end date:
2028-03-20
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the appropriate dosage, safety and effectiveness of the study drug, IPN01194 in adults with advanced solid tumours.
The participants in this study will have advanced solid tumours. 'Advanced solid tumours' refers to cancers that can occur in several places, including cancers in organs or tissues that have spread from their original site to nearby tissues or other parts of the body.
In this study, all participants will receive the study drug, which will be taken by mouth (orally).